Unusual presentation of lumbar chordoma on bone scintigraphy in a young patient | ||
| Asia Oceania Journal of Nuclear Medicine and Biology | ||
| مقاله 13، دوره 9، شماره 1، فروردین 2021، صفحه 76-79 اصل مقاله (713.04 K) | ||
| نوع مقاله: Case report | ||
| شناسه دیجیتال (DOI): 10.22038/aojnmb.2020.48929.1331 | ||
| نویسندگان | ||
| Yasaman Fakhar؛ Golnaz Gholami؛ Zahra Bakhshi golestani؛ Ramin Sadeghi؛ Vahidreza Dabbagh Kakhki* | ||
| Nuclear Medicine Research Center, Mashhad University of Medical Science, Mashhad, Iran | ||
| چکیده | ||
| Chordoma is a rare bone cancer which arises from undifferentiated notochordal remnants in the axial skeleton. It generally has slow-growing and locally aggressive behavior. This tumor is usually diagnosed by CT and MRI modalities and the role of SPECT/CT is still debated. It shows reduced or normal uptake of radioisotope on bone scanning and increased tracer uptake is infrequently reported. Here we present a 33-year-old man with complaint of low back pain and numbness of his right leg. The whole body bone scan showed relatively uniform radiotracer activity throughout the skeleton. A focal increased uptake in the second lumbar vertebra was noted on SPECT/CT images. SPECT/CT also demonstrated multiple lytic lesions in lumbar vertebrae. The lesions were proven to be chordoma on biopsy. Lumbar chordoma could be one of the differential diagnoses for lytic lesions of the vertebrae which show absent or minimal tracer uptake on bone scintigraphy and SPECT/CT imaging. Our case was unusual as the patient was very young for chordoma diagnosis and bone scan showed increased uptake adjacent to the involved vertebral lesion detected by SPECT/CT. | ||
| کلیدواژهها | ||
| Chordoma؛ Bone scintigraphy؛ SPECT/CT؛ Lumbar spine؛ Nuclear medicine | ||
| مراجع | ||
|
1. Healey J, Lane J. Chordoma: a critical review of diagnosis and treatment. The Orthopedic clinics of North America. 1989; 20(3):417-26.
2. McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: incidence and survival patterns in the United States, 1973– 1995. Cancer Causes & Control. 2001;12(1):1-11.
3. Weber AL, Brown EW, Hug EB, Liebsch NJ. Cartilaginous tumors and chordomas of the cranial base. Otolaryngologic clinics of North America. 1995; 28(3):453-71.
4. Perzin KH, Pushparaj N. Nonepithelial tumors of the nasal cavity, paranasal sinuses, and nasopharynx: A clinicopathologic study. XIV: Chordomas. Cancer. 1986; 57(4):784-96.
5. Wold LE, Laws ER. Cranial chordomas in children and young adults. Journal of neurosurgery. 1983; 59(6):1043-7.
6. Horten BC, Montague SR. In vitro characteristics of a sacrococcygeal chordoma maintained in tissue and organ culture systems. Acta neuropathologica. 1976; 35(1):13-25.
7. Stark AM, Mehdorn HM. Chondroid clival chordoma. New England Journal of Medicine. 2003; 349(10):e10.
8. Kitai R, Yoshida K, Kubota T, Sato K, Handa Y, Kasahara K, et al. Clival chordoma manifesting as nasal bleeding. A case report. Neuroradiology. 2005; 47(5):368-71.
9. Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Meis‐Kindblom JM. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2000; 88(9):2122-34.
10. Walcott BP, Nahed BV, Mohyeldin A, Coumans J-V, Kahle KT, Ferreira MJ. Chordoma: current concepts, management, and future directions. The lancet oncology. 2012; 13(2):e69-e76.
11. Santegoeds RG, Temel Y, Beckervordersandforth JC, Van Overbeeke JJ, Hoeberigs CM. State-of-the-art imaging in human chordoma of the skull base. Current radiology reports. 2018; 6(5):16.
12. Rossleigh MA, Smith J, Yeh S. Scintigraphic features of primary sacral tumors. Journal of nuclear medicine: official publication, Society of Nuclear Medicine. 1986; 27(5):627-30.
13. Kaiser TE, Pritchard DJ, Unni KK. Clinicopathologic study of sacrococcygeal chordoma. Cancer. 1984; 53(11):2574-8.
14. Yonemoto T, Tatezaki Si, Takenouchi T, Ishii T, Satoh T, Moriya H. The surgical management of sacrococcygeal chordoma. Cancer: Interdisciplinary International Journal of the American Cancer Society. 1999; 85(4):878-83.
15. Boriani S, Chevalley F, Weinstein JN, Biagini R, Campanacci L, De Iure F, et al. Chordoma of the spine above the sacrum: treatment and outcome in 21 cases. Spine. 1996; 21(13):1569-77.
16. Wu Z, Zhang J, Zhang L, Jia G, Tang J, Wang L, et al. Prognostic factors for long-term outcome of patients with surgical resection of skull base chordomas—106 cases review in one institution. Neurosurgical review. 2010; 33(4):451-6.
17. Stacchiotti S, Casali PG, Vullo SL, Mariani L, Palassini E, Mercuri M, et al. Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers. Annals of surgical oncology. 2010; 17(1):211-9.
18. Fourney DR, Gokaslan ZL. Current management of sacral chordoma. Neurosurgical focus. 2003; 15(2):1-5.
19. Kamaleshwaran K, Bhattacharya A, Harisankar C, Goni V, Mittal B. Sacrococcygeal chordoma: Increased 99m Tc methylene diphosphonate uptake on single photon emission computed tomography/computed tomography bone scintigraphy. Indian Journal of Nuclear Medicine: IJNM. 2012; 27(3):199.
20. Rohatgi S, Ramaiya NH, Jagannathan JP, Howard SA, Shinagare AB, Krajewski KM. Metastatic chordoma: report of the two cases and review of the literature. The Eurasian journal of medicine. 2015; 47(2):151. | ||
|
آمار تعداد مشاهده مقاله: 567 تعداد دریافت فایل اصل مقاله: 379 |
||